INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
HOUSE PTR/PurchaseVerified data

Gilbert Ray Cisneros, Jr. bought AORT

Self · ARTIVION, INC. · Artivion, Inc. Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Aug 20, 2026
Disclosed
Sep 10, 2026
Disclosure timeline21 days from execution to publication · legal deadline 45 days
Aug 20 executedSep 10, 2026 disclosed

AORT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
20/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

Filing timing0 / 15

Disclosed 21 days after execution (STOCK Act deadline: 45)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · AORT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    35
    GM
    Green Andrew MSVP, Regulatory and Quality
    AORTARTIVION, INC.
    Open-market sale
    		SELL$287K
    11.5K sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    39
    Gilbert Ray Cisneros, Jr.DSelf
    AORTARTIVION, INC.
    Purchase
    		BUY$1,001 – $15KJul 16, 2026Sep 4, 2026
    traded Jul 16, 2026
    		+50dHOUSE PTR

    Evidence

    19
    MP
    Mackin James PPresident & CEO
    AORTARTIVION, INC.
    Open-market sale · 10b5-1 plan
    		SELL$1.41M
    30.9K sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    29
    HF
    Holloway Jean FSVP, General Counsel
    AORTARTIVION, INC.
    Open-market sale
    		SELL$239K
    5,267 sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    5
    MP
    Mackin James PPresident & CEO
    AORTARTIVION, INC.
    Option exercise · 10b5-1 plan
    		M$916K
    30.9K sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    29
    HF
    Holloway Jean FSVP, General Counsel
    AORTARTIVION, INC.
    Open-market sale
    		SELL$93K
    2,048 sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    0
    MP
    Mackin James PPresident & CEO
    AORTARTIVION, INC.
    Option exercise · 10b5-1 plan
    		M—
    30.9K sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20035390

    Timestamps

    Event (reported)
    Aug 20, 2026
    Published
    Sep 10, 2026
    Ingested by INSIDER
    Nov 4, 22:39 UTC
    Last re-read
    Nov 6, 23:31 UTC

    Extracted facts

    Filer
    Gilbert Ray Cisneros, Jr.
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    Artivion, Inc. Common Stock
    Ticker
    AORT
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Aug 20, 2026
    Notification date (reported)
    Sep 4, 2026
    Days from execution to publication
    21

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Gilbert Ray Cisneros, Jr. reported a purchase of Artivion, Inc. Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Gilbert Ray Cisneros, Jr.bioguide:C001123
    Issuer
    ARTIVION, INC.cik:0000784199

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.